Motley Fool Asset Management LLC Sells 902 Shares of UiPath Inc. (NYSE:PATH)

Motley Fool Asset Management LLC trimmed its stake in shares of UiPath Inc. (NYSE:PATH) by 9.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,174 shares of the healthcare company’s stock after selling 902 shares during the period. Motley Fool Asset Management LLC’s holdings in UiPath were worth $228,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PATH. State of New Jersey Common Pension Fund D increased its position in UiPath by 3.5% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 231,613 shares of the healthcare company’s stock valued at $5,753,000 after acquiring an additional 7,918 shares during the last quarter. GAMMA Investing LLC bought a new stake in shares of UiPath during the 4th quarter valued at about $36,000. New York State Common Retirement Fund increased its position in shares of UiPath by 19.0% during the 4th quarter. New York State Common Retirement Fund now owns 363,056 shares of the healthcare company’s stock valued at $9,018,000 after purchasing an additional 58,064 shares during the last quarter. California Public Employees Retirement System lifted its stake in shares of UiPath by 13.9% in the 4th quarter. California Public Employees Retirement System now owns 641,825 shares of the healthcare company’s stock worth $15,943,000 after purchasing an additional 78,459 shares during the period. Finally, Sigma Planning Corp purchased a new position in shares of UiPath in the fourth quarter worth approximately $809,000. Institutional investors own 62.50% of the company’s stock.

UiPath Stock Up 0.3 %

Shares of PATH opened at $19.46 on Friday. The business’s 50 day simple moving average is $22.19 and its 200-day simple moving average is $21.55. UiPath Inc. has a 1 year low of $12.38 and a 1 year high of $27.87.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The business had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. Research analysts predict that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Buying and Selling at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of the business’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $22.84, for a total transaction of $365,440.00. Following the transaction, the chief financial officer now owns 87,505 shares of the company’s stock, valued at approximately $1,998,614.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have sold a total of 72,000 shares of company stock worth $1,591,360 over the last ninety days. Company insiders own 31.03% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on PATH. KeyCorp started coverage on shares of UiPath in a research report on Monday, April 8th. They issued an “overweight” rating and a $27.00 price target on the stock. Evercore ISI lifted their target price on UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a research report on Thursday, March 14th. DA Davidson raised their price objective on UiPath from $20.00 to $24.00 and gave the stock a “neutral” rating in a research note on Thursday, March 14th. William Blair began coverage on UiPath in a research note on Tuesday, January 2nd. They set an “outperform” rating for the company. Finally, BMO Capital Markets raised their price objective on shares of UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a research report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.41.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.